FDA chief outlines new ways to speed cancer drug approvals Ruby Khatun Khatun6 Jun 2018 9:45 AM ISTCHICAGO: The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up...
Novartis readies anti-sexism message for migraine drug Ruby Khatun Khatun6 Jun 2018 9:30 AM ISTZURICH: With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it...
Dr Reddy's Lab shares gain 3 percent on zero USFDA observations for Srikakulam plant Ruby Khatun Khatun5 Jun 2018 10:30 AM ISTNew Delhi: Shares of Dr Reddys Laboratories rose by nearly 3 percent after the company said the USFDA has completed its API Srikakulam plant audit...
18 held for smuggling banned medicinal plants in Bandipora Ruby Khatun Khatun5 Jun 2018 10:15 AM ISTSrinagar: Jammu and Kashmir police claimed to have arrested 18 persons for smuggling banned medicinal plants in north Kashmir district of Bandipora, a...
FDA wants to shorten new drug monopolies to cut costs Ruby Khatun Khatun5 Jun 2018 10:00 AM ISTCHICAGO: In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval...
FDA approves lower dose of Eli Lilly-Incyte arthritis drug Ruby Khatun Khatun5 Jun 2018 9:45 AM ISTThe U.S. Food and Drug Administration approved the lower dose of a rheumatoid arthritis drug developed by Eli Lilly and Incyte Corp but declined to...
Zydus gets final nod from USFDA for anti-bacterial drug Ruby Khatun Khatun4 Jun 2018 10:30 AM ISTNew Delhi: Zydus Cadila has received the final approval from the USFDA to market Doxycycline Hyclate capsules USP, antibiotic used for treating...
Dr Reddy's expects to launch over 15 products in US in FY'19 Ruby Khatun Khatun4 Jun 2018 10:15 AM ISTNew Delhi: Dr Reddy's Laboratories expects to launch over 15 products in the US market in 2018-19, according to a top company official.The...
Alembic Pharma plans Rs 720-crore capex for FY19 Ruby Khatun Khatun4 Jun 2018 10:00 AM ISTAlembic Pharmaceuticals has earmarked a capital expenditure of Rs 720 crore for this fiscal year to complete existing projects and on maintenance, a...
Roche's Perjeta wins approval in Europe for expanded use Ruby Khatun Khatun4 Jun 2018 9:45 AM ISTZURICH: Roche won European Union approval for its Perjeta medicine to treat a type of breast cancer whose sufferers are at a high risk of...
Merck's Keytruda extends lung cancer survival in two trials Ruby Khatun Khatun4 Jun 2018 9:30 AM ISTCHICAGO: Merck & Co’s immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with...
Gap in regulating biotech drug copies prompts WHO to step in Ruby Khatun Khatun3 Jun 2018 10:30 AM ISTLONDON: Cut-price copies of expensive biotech drugs promise to slash the cost of treating serious diseases, including cancer, in rich and poor...
